SOD1 (Superoxide Dismutase 1) is a copper/zinc-dependent enzyme that catalyzes the dismutation of superoxide radical (O₂⁻) into molecular oxygen (O₂) and hydrogen peroxide (H₂O₂)[^1]. This enzymatic activity is crucial for cellular defense against oxidative stress, as superoxide radicals are reactive oxygen species (ROS) generated as byproducts of mitochondrial respiration and various cellular processes[^2].[@m2019] Mutations in the SOD1 gene were the first genetic cause of amyotrophic lateral sclerosis (ALS) to be identified, accounting for approximately 12-20% of familial ALS cases and 1-2% of sporadic ALS cases[^3].[@k2018] The discovery of SOD1 mutations in ALS in 1993 established the field of genetic neurodegeneration research and has provided critical insights into the pathogenesis of ALS and related disorders[^4].
[^1]: McCord JM, Fridovich I. (1969). Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). Journal of Biological Chemistry 244:6049-6055. PMID: 5387890(https://pubmed.ncbi.nlm.nih.gov/5387890/)
[^2]: Finkel T, Holbrook NJ. (2000). Oxidants, oxidative stress and the biology of ageing. Nature 408:239-247. PMID: 11089981(https://pubmed.ncbi.nlm.nih.gov/11089981/)
[^3]: Renton AE, Chio A, Traynor BJ. (2014). State of play in ALS genetics. Nature Reviews Neurology 10:291-307. PMID: 24740861(https://pubmed.ncbi.nlm.nih.gov/24740861/)
SOD1 (Superoxide Dismutase 1) is a copper/zinc-dependent enzyme that catalyzes the dismutation of superoxide radical (O₂⁻) into molecular oxygen (O₂) and hydrogen peroxide (H₂O₂)[^1]. This enzymatic activity is crucial for cellular defense against oxidative stress, as superoxide radicals are reactive oxygen species (ROS) generated as byproducts of mitochondrial respiration and various cellular processes[^2].[@m2019] Mutations in the SOD1 gene were the first genetic cause of amyotrophic lateral sclerosis (ALS) to be identified, accounting for approximately 12-20% of familial ALS cases and 1-2% of sporadic ALS cases[^3].[@k2018] The discovery of SOD1 mutations in ALS in 1993 established the field of genetic neurodegeneration research and has provided critical insights into the pathogenesis of ALS and related disorders[^4].
[^1]: McCord JM, Fridovich I. (1969). Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). Journal of Biological Chemistry 244:6049-6055. PMID: 5387890(https://pubmed.ncbi.nlm.nih.gov/5387890/)
[^2]: Finkel T, Holbrook NJ. (2000). Oxidants, oxidative stress and the biology of ageing. Nature 408:239-247. PMID: 11089981(https://pubmed.ncbi.nlm.nih.gov/11089981/)
[^3]: Renton AE, Chio A, Traynor BJ. (2014). State of play in ALS genetics. Nature Reviews Neurology 10:291-307. PMID: 24740861(https://pubmed.ncbi.nlm.nih.gov/24740861/)
[^4]: Rosen DR, et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62. PMID: 7683886(https://pubmed.ncbi.nlm.nih.gov/7683886/)
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">SOD1 — Superoxide Dismutase 1</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Superoxide Dismutase [Cu-Zn]</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SOD1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>21q22.11</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[6647](https://www.ncbi.nlm.nih.gov/gene/6647)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P00441](https://www.uniprot.org/uniprot/P00441)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>154 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~16 kDa (monomer)</td></tr>
<tr><td><strong>PDB IDs</strong></td><td>1HL5, 1HL4, 2C9V, 4A7U, 6DO5</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Superoxide dismutase (Cu/Zn) family</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytoplasm, Nucleus, Mitochondria (intermembrane space)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia</td></tr>
</table>
</div>
The superoxide dismutase family comprises three isoforms in humans: SOD1 (copper/zinc SOD, cytosolic), SOD2 (manganese SOD, mitochondrial), and SOD3 (extracellular SOD)[^5]. SOD1 is the most abundant isoform and is expressed in virtually all cell types, with particularly high expression in [neurons](/cell-types/neurons) and [astrocytes](/cell-types/astrocytes)[^6]. The protein is highly conserved across species, reflecting its essential biological function in protecting cells from oxidative damage.
[^5]: Culotta VC, et al. (1997). Mapping the copper binding site in yeast Cu,Zn-superoxide dismutase. Journal of Biological Chemistry 272:23469-23472. PMID: 9295279(https://pubmed.ncbi.nlm.nih.gov/9295279/)
[^6]: Pardo CA, et al. (1995). Cu,Zn superoxide dismutase (SOD1) in spinal cord of ALS. Proceedings of the National Academy of Sciences 92:934-938. PMID: 7846080(https://pubmed.ncbi.nlm.nih.gov/7846080/)
SOD1 is notable not only for its enzymatic function but also for its involvement in neurodegenerative diseases. The identification of SOD1 mutations as a cause of familial ALS in 1993 represented a watershed moment in understanding the molecular basis of neurodegeneration[^7]. Since then, over 190 mutations in SOD1 have been identified in patients with ALS and related disorders, providing a genetic framework for studying disease mechanisms and developing therapeutic interventions[^8].[@a2025]
[^7]: Deng HX, et al. (1993). Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261:1047-1051. PMID: 8351519(https://pubmed.ncbi.nlm.nih.gov/8351519/)
[^8]: Abel O, et al. (2012). ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Human Mutation 33:1345-1351. PMID: 22549955(https://pubmed.ncbi.nlm.nih.gov/22549955/)
SOD1 is a 154-amino acid protein with a molecular weight of approximately 16 kDa per monomer. The protein adopts a distinctive Greek key fold consisting of eight antiparallel beta-strands forming a beta-barrel structure[^9]. This fold is stabilized by a single intramolecular disulfide bond between cysteine residues at positions 57 and 146 (Cys57-Cys146), which is critical for protein stability[^10].
[^9]: Tainer JA, et al. (1982). Determination and analysis of the 2 A structure of copper,zinc superoxide dismutase. Journal of Molecular Biology 160:181-217. PMID: 6983633(https://pubmed.ncbi.nlm.nih.gov/6983633/)
[^10]: Culotta VC, et al. (1997). The copper chaperone for superoxide dismutase. Journal of Biological Chemistry 272:23469-23472. PMID: 9295279(https://pubmed.ncbi.nlm.nih.gov/9295279/)
SOD1 functions as a homodimer, with two monomers associate through hydrophobic interactions at the dimer interface[^11]. Each monomer contains:
[^11]: Bertini I, et al. (1994). Copper-zinc superoxide dismutase: a spectroscopic investigation. Journal of Inorganic Biochemistry 53:253-270. PMID: 8206726(https://pubmed.ncbi.nlm.nih.gov/8206726/)
[^12]: Deng HX, et al. (1993). Different mutations in SOD1 associated with familial ALS. Science 264:1772-1775. PMID: 8209258(https://pubmed.ncbi.nlm.nih.gov8209258/)
SOD1 requires both copper and zinc ions for full enzymatic activity:
Copper is essential for catalytic activity and participates in the dismutation reaction through a redox cycle:
Zinc serves a structural role, stabilizing the protein fold and dimer interface without directly participating in catalysis[^13].
[^13]: Valentine JS, et al. (2005). Copper-zinc superoxide dismutase and ALS. Proceedings of the National Academy of Sciences 102:8251-8253. PMID: 15939860(https://pubmed.ncbi.nlm.nih.gov/15939860/)
Over 190 ALS-associated mutations affect various aspects of SOD1 structure and function[^14]:
| Mutation Type | Effect on SOD1 |
|--------------|----------------|
| Stability mutations (e.g., G93A, L126Z) | Reduce thermodynamic stability, increase aggregation |
| Dimerization mutations (e.g., L127X) | Disrupt dimer interface |
| Metal binding mutations (e.g., H46R, H48Q) | Impair metal ion coordination |
| Disulfide bond mutations (e.g., C57G) | Disrupt structural disulfide |
[^14]: Kaur SJ, et al. (2016). The SOD1 in ALS: About structure and the effect of pathogenic mutations. Journal of Neurology 263:191-197. PMID: 26537552(https://pubmed.ncbi.nlm.nih.gov/26537552/)
SOD1's primary function is to catalyze the dismutation of superoxide radical (O₂⁻) into hydrogen peroxide (H₂O₂) and molecular oxygen (O₂)[^15]:
2 O₂⁻ + 2 H⁺ → O₂ + H₂O₂
This reaction is critical for cellular homeostasis because superoxide radicals are generated continuously as byproducts of normal cellular respiration, particularly from mitochondrial complex I and complex III[^16]. Unchecked superoxide accumulation leads to:
[^16]: Turrens JF. (1997). Mitochondrial formation of reactive oxygen species. Journal of Physiology 522:335-344. PMID: 9173914(https://pubmed.ncbi.nlm.nih.gov/9173914/)
SOD1 is distributed across multiple cellular compartments[^17]:
In the nervous system, SOD1 plays particularly important roles[^18]:
SOD1 mutations cause approximately 12-20% of familial ALS cases and 1-2% of sporadic ALS cases[^19]. Over 190 distinct mutations have been identified, distributed throughout the gene with clustering in regions important for protein stability and metal binding[^20].
[^19]: Chio A, et al. (2018). Genetic landscape of sporadic ALS. Lancet Neurology 17:318-324. PMID: 29500154(https://pubmed.ncbi.nlm.nih.gov/29500154/)
[^20]: ALSoD Database. (2023). SOD1 mutations in ALS. [https://alsod.iop.kcl.ac.uk/](https://alsod.iop.kcl.ac.uk/)
Common pathogenic mutations include:
| Mutation | Prevalence | Characteristics |
|----------|------------|-----------------|
| A4V | Most common in North America | Aggressive, rapid progression |
| G93A | Common in research models | High aggregation propensity |
| G37R | North American/European | Intermediate progression |
| L126Z | Japanese populations | Severe, early onset |
| H46R | Asian populations | Slow progression |
| D90A | Scandinavian descent | Variable, often slow |
Mutant SOD1 causes ALS through a toxic gain-of-function mechanism rather than loss of enzymatic activity[^21]. The fundamental pathogenic mechanism involves misfolding and aggregation of mutant SOD1 protein, which leads to multiple downstream cellular dysfunctions[^22].
[^21]: Cleveland DW, Rothstein JD. (2001). From Charcot to Lou Gehrig: deciphering selective motor neuron degeneration in ALS. Nature Reviews Neuroscience 2:806-819. PMID: 11715057(https://pubmed.ncbi.nlm.nih.gov/11715057/)
[^22]: Boillee S, Cleveland DW. (2008). Revisiting oxidative damage in ALS. Neuron 58:8-10. PMID: 18400155(https://pubmed.ncbi.nlm.nih.gov/18400155/)
Mutant SOD1 triggers neurodegeneration through multiple interconnected mechanisms[^23]:
[^23]: Ilieva H, Polymenidou M, Cleveland DW. (2009). Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. Journal of Cell Biology 187:761-772. PMID: 19951898(https://pubmed.ncbi.nlm.nih.gov/19951898/)
1. Protein Misfolding and Aggregation
Mutant SOD1 proteins have reduced thermodynamic stability and tend to misfold, forming toxic oligomers and insoluble aggregates[^24]:
2. Mitochondrial Dysfunction
Mutant SOD1 directly impairs mitochondrial function[^25]:
3. Axonal Transport Defects
Mutant SOD1 disrupts axonal transport through[^26]:
4. ER Stress and Unfolded Protein Response
Mutant SOD1 triggers endoplasmic reticulum stress[^27]:
5. Excitotoxicity
Mutant SOD1 contributes to glutamate-mediated excitotoxicity[^28]:
6. Neuroinflammation
Mutant SOD1 activates glial cells[^29]:
SOD1 transgenic mice recapitulate key features of human ALS and have been essential for understanding disease mechanisms[^30]:
[^30]: Gurney ME, et al. (1994). Motor neuron degeneration in mice expressing mutant SOD1. Science 264:1772-1775. PMID: 8209258(https://pubmed.ncbi.nlm.nih.gov/8209258/)
| Model | Mutation | Characteristics |
|-------|----------|-----------------|
| G93A | G93A | Rapid progression, commonly used |
| G37R | G37R | Slower progression |
| L127X | L127Z | Very rapid progression |
| D83G | D83G | Intermediate progression |
Phenotypic characteristics:
Drosophila melanogaster:
Zebrafish:
C. elegans:
SOD1 activity is altered in Alzheimer's disease[^34]:
SOD1 may play a role in [Parkinson's disease](/diseases/parkinsons-disease)[^35]:
SOD1 mutations can cause frontotemporal dementia (FTD) without ALS in some cases[^36]:
SOD1 alterations have been reported in Huntington's disease[^37]:
1. Gene Silencing
2. Gene Replacement
1. Active Vaccination
2. Passive Immunization
1. Antioxidants
2. Mitochondrial Protectants
4. Anti-excitotoxic
Cerebrospinal fluid:
Blood:
| Year | Discovery |
|------|-----------|
| 1969 | Discovery of SOD enzymatic activity (McCord and Fridovich) |
| 1973 | Crystal structure of SOD1 determined |
| 1987 | SOD1 gene mapped to chromosome 21 |
| 1993 | SOD1 mutations linked to familial ALS |
| 1994 | First SOD1 transgenic mouse model |
| 2001 | Non-cell autonomous mechanism discovered |
| 2006 | First antisense oligonucleotide trial |
| 2017 | Edaravone approved for ALS |
| 2020 | First RNAi therapy in clinical trials |
The following diagram shows the key molecular relationships involving SOD1 Protein discovered through SciDEX knowledge graph analysis: